RASMI BHATTARAI: Open Payments
NPI 1831886530 · ELLICOTT CITY, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$184 in 9 payments from 8 companies in 2025. Trend: 2023 $13 · 2024 $319 · 2025 $184
Food & beverage: $184
| Company | Payments | Amount |
|---|---|---|
| Indivior Inc. | 2 | $49 |
| Janssen Pharmaceuticals, Inc | 1 | $33 |
| E.R. Squibb & Sons, L.L.C. | 1 | $21 |
| Teva Pharmaceuticals USA, Inc. | 1 | $20 |
| TMS NeuroHealth Centers Inc. | 1 | $17 |
| Supernus Pharmaceuticals, Inc. | 1 | $15 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $15 |
| Vanda Pharmaceuticals Inc. | 1 | $14 |
Products named: SUBLOCADE, SPRAVATO, COBENFY, AUSTEDO XR, TMS NeuroHealth Centers Inc., Qelbree, CAPLYTA, FANAPT.
Industry payments across MD — which companies pay providers there.
